Financial News
Articles published by bluebird bio, Inc.
![](https://mms.businesswire.com/media/20240823097360/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Announces Receipt of Expected Notices from Nasdaq
August 23, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240814882522/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
August 14, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240812763842/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Announces Second Quarter 2024 Results Call Date
August 12, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240802449243/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240703608690/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240529060961/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240509280117/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240506060424/en/670463/5/bluebird_logo.jpg)
bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
May 06, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240506914645/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20240426834938/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240411929911/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240326211450/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240325541893/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240318783958/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20240311251950/en/670463/5/bluebird_logo.jpg)
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
March 11, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240108221653/en/670463/5/bluebird_logo.jpg)
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
January 08, 2024
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20240102188681/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20231219687449/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
December 19, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20231218251755/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
December 18, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20231209852325/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20231209650405/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20231208301760/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20231208492260/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20231107552972/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
November 07, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20231102164140/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20231030674385/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Enters into Advance Agreement to Sell Priority Review Voucher, if Granted, for $103 Million
October 30, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20231024153256/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20230905255288/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Announces September Investor Events
September 05, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
![](https://mms.businesswire.com/media/20230816191251/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20230808850512/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio Reports Second Quarter 2023 Financial Results and Highlights Operational Progress
August 08, 2023
From bluebird bio, Inc.
Via Business Wire
Tickers
BLUE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.